Skip to main content
main-content

Zeitschrift

Annals of Hematology

Annals of Hematology 1/2021

Ausgabe 1/2021

Inhaltsverzeichnis ( 36 Artikel )

03.10.2020 | Review Article | Ausgabe 1/2021

Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn

Ioannis Koutsavlis

02.10.2020 | Review Article | Ausgabe 1/2021 Open Access

Is there a gender effect in polycythemia vera?

Francesca Palandri, Barbara Mora, Naseema Gangat, Lucia Catani

01.09.2020 | Original Article | Ausgabe 1/2021 Open Access

An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia

Sylvie Stacy, Sujit Sheth, Brandon Coleman, Wendy Cerenzia

12.09.2020 | COVID-19 | Original Article | Ausgabe 1/2021 Zur Zeit gratis

Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection

Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, Mashael M. Alanazi, Mohammed F. Almutairi, Ibrahim M. Aldeailej, Najeeb A. Kamli, Mahmoud D. Aljurf

20.10.2020 | COVID-19 | Original Article | Ausgabe 1/2021

Characteristics of coagulation alteration in patients with COVID-19

Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu

08.10.2020 | Original Article | Ausgabe 1/2021

Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine

Yang Lan, Lixian Chang, Meihui Yi, Yuli Cai, Jing Feng, Yuanyuan Ren, Chao Liu, Xiaoyan Chen, Shuchun Wang, Ye Guo, Aoli Zhang, Lipeng Liu, Jingliao Zhang, Xiaofan Zhu

16.06.2020 | Original Article | Ausgabe 1/2021

Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia

Filipe Martins, Michael Kruszewski, Ilaria Scarpelli, Jacqueline Schoumans, Olivier Spertini, Michael Lübbert, Sabine Blum

01.09.2020 | Original Article | Ausgabe 1/2021

Antibiotic use during cytarabine consolidation in acute myeloid leukemia

Colin A. Vale, Pamela C. Egan, Randall Ingham, Dimitrios Farmakiotis, John L. Reagan

06.10.2020 | Original Article | Ausgabe 1/2021

Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India

Abhijit Phukan, Prakas Kumar Mandal, Tuphan K. Dolai

26.10.2020 | Original Article | Ausgabe 1/2021 Open Access

Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm

David C. A. Molitor, Peter Boor, Andreas Buness, Rebekka K. Schneider, Lino L. Teichmann, Ruth-Miriam Körber, Gabor L. Horvath, Steffen Koschmieder, Ines Gütgemann

21.10.2020 | Original Article | Ausgabe 1/2021

Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis

Benedetta Rambaldi, Elisa Diral, Samantha Donsante, Noemi Di Marzo, Federica Mottadelli, Lucia Cardinale, Erica Dander, Giuseppe Isimbaldi, Pietro Pioltelli, Andrea Biondi, Mara Riminucci, Giovanna D’Amico, Elena Maria Elli, Alice Pievani, Marta Serafini

31.10.2020 | Original Article | Ausgabe 1/2021

Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019

Konnie Hebeda, Ludmila Boudova, Christine Beham-Schmid, Attilio Orazi, Hans-Michael Kvasnicka, Umberto Gianelli, Alexandar Tzankov

20.10.2020 | Original Article | Ausgabe 1/2021

Low-dose ruxolitinib shows effective in treating myelofibrosis

Yunfan Yang, Hongmei Luo, Yuhuan Zheng, Zhongqing Zou, Ting Niu, Yongqian Jia, Huanling Zhu, Ting Liu, Yu Wu, Hong Chang, Jie Ji, Jian Li, Ling Pan

01.06.2020 | Original Article | Ausgabe 1/2021

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

William J. Archibald, Kari G. Rabe, Brian F. Kabat, Joerg Herrmann, Wei Ding, Neil E. Kay, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Yucai Wang, Asher A. Chanan-Khan, Susan M. Schwager, Amber B. Koehler, Amie L. Fonder, Susan L. Slager, Tait D. Shanafelt, Timothy G. Call, Sameer A. Parikh

21.10.2020 | Original Article | Ausgabe 1/2021

Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry

Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa

28.11.2020 | Correction | Ausgabe 1/2021

Correction to: Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry

Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa

07.11.2020 | Original Article | Ausgabe 1/2021

Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide

Jiao-Yu Zhao, Si-Ning Liu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Yu-Hong Chen, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo

28.10.2020 | Original Article | Ausgabe 1/2021 Open Access

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors

Catharina Van Elssen, Gwendolyn van Gorkom, Christine Voorter, Peter von dem Borne, Ellen Meijer, Lotte Wieten, Gerard Bos

17.11.2020 | Original Article | Ausgabe 1/2021

Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas

Jae-Cheol Jo, Jin-Seok Kim, Je-Hwan Lee, Jung-Hee Lee, Seong Nam Im, Sang-Min Lee, Sung-Soo Yoon, In-Ho Kim, Seong Hwa Bae, Yoo Jin Lee, Yunsuk Choi, Won-Sik Lee

05.11.2020 | Original Article | Ausgabe 1/2021

Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study

Yasuo Mori, Kensuke Sasaki, Yoshikiyo Ito, Takuro Kuriyama, Toshiyuki Ueno, Masanori Kadowaki, Takatoshi Aoki, Takeshi Sugio, Goichi Yoshimoto, Koji Kato, Takahiro Maeda, Koji Nagafuji, Koichi Akashi, Toshihiro Miyamoto, Fukuoka Blood and Marrow Transplantation Group

23.10.2020 | Original Article | Ausgabe 1/2021 Open Access

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

Claire Seydoux, Michael Medinger, Sabine Gerull, Joerg Halter, Dominik Heim, Yves Chalandon, Stavroula Masouridi Levrat, Urs Schanz, Gayathri Nair, Marc Ansari, Patrick Simon, Jakob R. Passweg, Nathan Cantoni

09.10.2020 | Original Article | Ausgabe 1/2021

Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia

Yasushi Onishi, Takehiko Mori, Hirohito Yamazaki, Katsuto Takenaka, Hiroki Yamaguchi, Naoki Shingai, Yukiyasu Ozawa, Hiroatsu Iida, Shuichi Ota, Naoyuki Uchida, Toshihiro Miyamoto, Yuta Katayama, Jun Kato, Satoshi Yoshioka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, on behalf of the Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

12.09.2020 | Original Article | Ausgabe 1/2021

Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study

Andry Van de Louw, Kathleen Twomey, Nicholas Habecker, Kevin Rakszawski

30.09.2020 | Original Article | Ausgabe 1/2021 Open Access

Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Boris Böll, Enrico Schalk, Dieter Buchheidt, Justin Hasenkamp, Michael Kiehl, Til Ramon Kiderlen, Matthias Kochanek, Michael Koldehoff, Philippe Kostrewa, Annika Y. Claßen, Sibylle C. Mellinghoff, Bernd Metzner, Olaf Penack, Markus Ruhnke, Maria J. G. T. Vehreschild, Florian Weissinger, Hans-Heinrich Wolf, Meinolf Karthaus, Marcus Hentrich

17.10.2020 | Original Article | Ausgabe 1/2021 Open Access

Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study

Loes L. Cornelissen, Aukje L. Kreuger, Camila Caram-Deelder, Rutger A. Middelburg, Jean Louis H. Kerkhoffs, Peter A. von dem Borne, Erik A. M. Beckers, Karen M. K. de Vooght, Jürgen Kuball, J. J. Zwaginga, Johanna G. van der Bom

13.02.2020 | Letter to the Editor | Ausgabe 1/2021

An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium

Qiaoyan Han, Lan Tao, Xin Jiang, Haoyue Chen, Chunhua Liu, Miao Sun

20.03.2020 | Letter to the Editor | Ausgabe 1/2021 Open Access

Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation

Annalen Bleckmann, Sascha Dierks, Hans-Ulrich Schildhaus, Niels Hellige, Ulrike Bacher, Lorenz Trümper, Gerald Wulf

27.03.2020 | Letter to the Editor | Ausgabe 1/2021

Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant

Manu Jamwal, Anu Aggarwal, Prashant Sharma, Deepak Bansal, Reena Das

19.03.2020 | Letter to the Editor | Ausgabe 1/2021

Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma

Camille Debord, Jessie Bourcier, François Subiger, François Leclair, Cyrille Touzeau, Thomas Gastinne, Anne Moreau, Olivier Theisen, Catherine Godon, Nelly Robillard, Yannick Le Bris, Marie C Béné, Soraya Wuillème

25.04.2020 | Letter to the Editor | Ausgabe 1/2021

Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment

Lu Zhang, Wei Zhang, Daobin Zhou

27.03.2020 | Letter to the Editor | Ausgabe 1/2021

Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia

Ozlem Ozbagcivan, Sevgi Akarsu, Ecem Canturk Nazli, Banu Lebe, Emel Fetil

08.04.2020 | Letter to the Editor | Ausgabe 1/2021

A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient

Jiaying Liu, Lijing Shen, Honghui Huang, Xiao Gao, Shan Mou, Liang Ying, Tingyu Yin

27.10.2020 | Correction | Ausgabe 1/2021

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Martin Kaiser, Meral Beksaç, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek, Philippe Moreau, Felipe de Arriba de la Fuente, María-Victoria Mateos, Sharon West, Andrew Spencer, S. Vincent Rajkumar, Kaveri Suryanarayan, Michael Czorniak, Cong Li, Zhaoyang Teng, Richard Labotka, Meletios A. Dimopoulos

21.11.2020 | Correction | Ausgabe 1/2021

Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments

Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, Alessandro Re, Chiara Pagani, Alessandra Tucci, Barbara Botto, Umberto Vitolo, Anna Lia Molinari, Benedetta Puccini, Alessandro Pulsoni, Armando Santoro, Monica Tani, Luca Nassi, Erika Meli, Vincenzo Pavone, Maurizio Bonfichi, Andrea Evangelista, Daniela Gioia, Alessandro Levis, Pierluigi Zinzani, Fondazione Italiana Linfomi (Onlus)

16.10.2020 | Correction | Ausgabe 1/2021

Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia

Ke Wan, Yafei Yin, Zimian Luo, Jianzhao Cheng

02.11.2020 | Correction | Ausgabe 1/2021

Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China

Jing Ruan, Wei Zuo, Miao Chen, Chen Yang, Bing Han

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise